Cargando…
Improving Riparin-A Dissolution through a Laponite Based Nanohybrid
(1) Background: Riparin-A presents several pharmacological activities already elucidated, such as antimicrobial modulator, antileishmania, anxiolytic, anti-inflammatory, antinociceptive, and antioxidant. Even with important bioactive effects, the applicability of Riparin-A is limited due to its low...
Autores principales: | Gomes, Duanne Mendes, Meirelles, Lyghia Maria Araújo, Araujo, Paulo Monteiro, de Sousa, Rayran Walter Ramos, Ferreira, Paulo Michel Pinheiro, Gutierrez, Stanley Juan Chavez, de Medeiros, Maria das Graças Freire, Raffin, Fernanda Nervo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458571/ https://www.ncbi.nlm.nih.gov/pubmed/37631350 http://dx.doi.org/10.3390/pharmaceutics15082136 |
Ejemplares similares
-
Antifungal and Antibiofilm Activity of Riparin III against Dermatophytes
por: Silva, Emanuel Pereira, et al.
Publicado: (2023) -
Solid-State Form Characterization of Riparin I
por: de Moura, Elisana Afonso, et al.
Publicado: (2017) -
Pharmacological Properties of Riparin IV in Models of Pain and Inflammation
por: Nascimento, Olívia Azevêdo, et al.
Publicado: (2016) -
Riparin-B as a Potential Inhibitor of AdeABC Efflux System from Acinetobacter baumannii
por: Leão, Patrícia Virna Sales, et al.
Publicado: (2023) -
Investigation into Brazilian Palygorskite for Its Potential Use as Pharmaceutical Excipient: Perspectives and Applications
por: Meirelles, Lyghia Maria Araújo, et al.
Publicado: (2023)